BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1473990)

  • 1. Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics.
    Tomoda H; Huang XH; Cao J; Nishida H; Nagao R; Okuda S; Tanaka H; Omura S; Arai H; Inoue K
    J Antibiot (Tokyo); 1992 Oct; 45(10):1626-32. PubMed ID: 1473990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terpendoles, novel ACAT inhibitors produced by Albophoma yamanashiensis. I. Production, isolation and biological properties.
    Huang XH; Tomoda H; Nishida H; Masuma R; Omura S
    J Antibiot (Tokyo); 1995 Jan; 48(1):1-4. PubMed ID: 7868384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages.
    Kogushi M; Tanaka H; Kobayashi H; Yamada T; Ohtsuka I; Kimura T; Saito I
    Jpn J Pharmacol; 1995 Jun; 68(2):191-9. PubMed ID: 7563976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative.
    Kusunoki J; Aragane K; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1995 Mar; 67(3):195-203. PubMed ID: 7630037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.
    Namatame I; Tomoda H; Ishibashi S; Omura S
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):737-42. PubMed ID: 14718664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purpactins, new inhibitors of acyl-CoA:cholesterol acyltransferase produced by Penicillium purpurogenum. I. Production, isolation and physico-chemical and biological properties.
    Tomoda H; Nishida H; Masuma R; Cao J; Okuda S; Omura S
    J Antibiot (Tokyo); 1991 Feb; 44(2):136-43. PubMed ID: 1750931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Maduskuie TP; Wilde RG; Billheimer JT; Cromley DA; Germain S; Gillies PJ; Higley CA; Johnson AL; Pennev P; Shimshick EJ
    J Med Chem; 1995 Mar; 38(7):1067-83. PubMed ID: 7707310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305.
    Tomoda H; Nishida H; Huang XH; Masuma R; Kim YK; Omura S
    J Antibiot (Tokyo); 1992 Aug; 45(8):1207-15. PubMed ID: 1399840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):357-65. PubMed ID: 9503394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes.
    Hernández ML; Martínez MJ; López de Heredia M; Ochoa B
    Biochim Biophys Acta; 1997 Nov; 1349(3):233-41. PubMed ID: 9434137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal long chain fatty acyl-CoA transacylation: differential effect of sterol carrier protein-2.
    Chao H; Billheimer JT; Kier AB; Schroeder F
    Biochim Biophys Acta; 1999 Aug; 1439(3):371-83. PubMed ID: 10498408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
    Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
    Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acaterin, a novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Pseudomonas sp. A92.
    Naganuma S; Sakai K; Hasumi K; Endo A
    J Antibiot (Tokyo); 1992 Aug; 45(8):1216-21. PubMed ID: 1399841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of acyl-CoA:cholesterol acyltransferase activity by brefeldin A in macrophage J774 cells.
    Hasumi K; Naganuma S; Koshizawa J; Mogi H; Endo A
    Biochim Biophys Acta; 1993 Apr; 1167(2):155-8. PubMed ID: 8466943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of acyl-CoA: cholesterol acyltransferase by isohalobacillin, a complex of novel cyclic acylpeptides produced by Bacillus sp. A1238.
    Hasumi K; Takizawa K; Takahashi F; Park JK; Endo A
    J Antibiot (Tokyo); 1995 Dec; 48(12):1419-24. PubMed ID: 8557597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethyl pyrocarbonate sensitivity.
    Kinnunen PM; DeMichele A; Lange LG
    Biochemistry; 1988 Sep; 27(19):7344-50. PubMed ID: 3207680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
    Harte RA; Yeaman SJ; Jackson B; Suckling KE
    Biochim Biophys Acta; 1995 Oct; 1258(3):241-50. PubMed ID: 7548193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit and human liver contain a novel pentacyclic triterpene ester with acyl-CoA: cholesterol acyltransferase inhibitory activity.
    Tabas I; Chen LL; Clader JW; McPhail AT; Burnett DA; Bartner P; Das PR; Pramanik BN; Puar MS; Feinmark SJ
    J Biol Chem; 1990 May; 265(14):8042-51. PubMed ID: 2335515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.